TGFB1 and myeloid sarcoma: Similar to IL-10-producing B cells [33–35], transforming growth factor (TGF)-β1-producing regulatory B cells have recently been shown by our group to restrain the initiation phase of experimental autoimmune neuroinflammation [36], making them potentially important in maintaining peripheral immune tolerance in organ-specific autoimmune disease such as MS.